G Lagrue Selected Research

Lipoid Nephrosis (Glomerulonephritis, Minimal Change)

7/2000

Vascular hyperpermeability in nephrotic edema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G Lagrue Research Topics

Disease

2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2003 - 05/2001
2	Tobacco Use Disorder (Nicotine Dependence) 07/2002 - 01/2002
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 03/2006
1	Hypoxia (Hypoxemia) 04/2003
1	Wounds and Injuries (Trauma) 04/2003
1	Depressive Disorder (Melancholia) 07/2002
1	Hypoalbuminemia 07/2000
1	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2000
1	Edema (Dropsy) 07/2000
1	Fibrosis (Cirrhosis) 07/2000
1	Hypothyroidism 07/2000
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 07/2000
1	Segmental glomerulosclerosis 07/2000
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 07/2000
1	Membranous Glomerulonephritis (Membranous Nephropathy) 07/2000

Drug/Important Bio-Agent (IBA)

4	Nicotine FDA Link 04/2003 - 05/2001
1	RotenoneIBA 04/2003
1	Dihydrotachysterol (AT 10)IBA 04/2003
1	Carbon MonoxideIBA 01/2002
1	CotinineIBA 01/2002
1	AlbuminsIBA 07/2000
1	DiureticsIBA 07/2000
1	IsotopesIBA 07/2000
1	SaltsIBA 07/2000
1	Technetium (Technetium 99m)IBA 07/2000

Therapy/Procedure

1	Tobacco Use Cessation Devices 03/2006
1	Therapeutics 07/2002